Recombinant CD7 (Grisnilimab Biosimilar) antibody

Catalog No. ABIN7675940

This Human Monoclonal antibody specifically detects CD7 (Grisnilimab Biosimilar) in BLI, ELISA, FACS, Func and SPR. It exhibits reactivity toward Human.

Quick Overview for Recombinant CD7 (Grisnilimab Biosimilar) antibody (ABIN7675940)

Target: CD7 (Grisnilimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CD7 (Grisnilimab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-CD7 (Grisnilimab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-CD7 Reference Antibody (grisnilimAb)

Characteristics: Anti-CD7 Reference Antibody (grisnilimAb) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hulambda. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG2SA

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for CD7 (Grisnilimab Biosimilar)

Target: CD7 (Grisnilimab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P09564